「腸泌素」有助逆轉？糖胖症恐增7倍死亡風險
LINE Today,
肥胖是種慢性病，比起正常體重者，肥胖者發生代謝疾病、糖尿病及高血脂風險更高，而一旦糖尿病病友的BMI指數大於27以上有肥胖情形，更要當心罹患「糖胖症」的死亡風險甚至提高至7倍。醫師指出，常聽到用於減重的「瘦瘦針」腸泌素藥物，可一次解決肥胖及糖尿病問題，搭配正…
Prevalence and outcomes of comorbid metabolic and cardiovascular conditions in middle- and older-age adults
Overview of attention for article published in Journal of Clinical Epidemiology, September 2001
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Readers on
- mendeley
- 77 Mendeley
